Antibody Response to COVID-19 mRNA Vaccines in Oncologic and Hematologic Patients Undergoing Chemotherapy

Background: Information on immune responses in cancer patients following mRNA COVID-19 vaccines is still insufficient, but generally, patients had impaired serological responses, especially those with hematological malignancies. We evaluated serological response to COVID-19 mRNA vaccine in cancer pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Mencoboni, Manlio, Fontana, Vincenzo, Damiani, Azzurra, Spitaleri, Antonino, Raso, Alessandro, Bottaro, Luigi Carlo, Rossi, Giovanni, Canobbio, Luciano, La Camera, Antonella, Filiberti, Rosa Angela, Taveggia, Paola, Cavo, Alessia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139308/
https://www.ncbi.nlm.nih.gov/pubmed/35621663
http://dx.doi.org/10.3390/curroncol29050273

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139308/
https://www.ncbi.nlm.nih.gov/pubmed/35621663
http://dx.doi.org/10.3390/curroncol29050273

Ejemplares similares